Godavari Drugs Ltd.
Snapshot View

76.05 +0.10 ▲0.1%

29 July 2021, 04:00:00 P.M.
Volume: 13,962

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.godavaridrugs.com
Financial Indicators
Market Cap 57.38 Cr.
Earnings per share (EPS) 5.48 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 13.90 Trailing Twelve Months Ending 2021-03
Industry PE 34.39 Trailing Twelve Months Ending 2021-03
Book Value / Share 32.38 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.35 Calculated using Price: 76.20
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.75 Cr. 7,530,500 Shares
FaceValue 10
Company Profile

Godavari Drugs was incorporated as a private limited company on December 2, 1987 and subsequently converted into a public limited company on September 25, 1992.  It was promoted by Ghanshyam Jaju, Mukund Kakani and PC Shrimal. 

The company has set up a project to manufacture 180 TPA at Sulphamethoxazole (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class ‘C’ backward district in Maharashtra. The project was fully commissioned on July 3, 1989.

The registered office of the company is located at Secunderabad in Andhra Pradesh and Mukund Kakani is its Managing Director.

Business area of the company

The company’s principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.13%
1 Week
-0.33%
1 Month
+21.49%
3 Month
+33.07%
6 Month
+80.64%
1 Year
+145.32%
2 Year
+302.38%
5 Year
+76.25%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -19.30 6.25 17.77 32.32 9.84 11.81 4.99 6.85 10.39
Return on Capital Employed (%) -14.54 9.32 8.18 32.30 15.77 16.89 11.01 12.14 11.80
Return on Assets (%) -10.87 3.18 10.41 14.70 3.17 3.41 1.40 1.77 2.54

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 7 8 10 13 14 16 17 18 20
Non Curr. Liab. 2 3 2 5 5 6 9 9 12
Curr. Liab. 6 4 3 17 31 34 37 46 51
Minority Int.
Equity & Liab. 15 15 15 35 51 56 63 74 84
Non Curr. Assets 8 8 8 8 10 13 16 17 23
Curr. Assets 7 7 6 27 40 43 47 56 61
Misc. Exp. not W/O
Total Assets 15 15 15 35 51 56 63 74 84

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 4 8 9 55 71 76 64 84 96
Other Income 0 0 0 0 0 1 1 0 0
Total Income 4 8 10 55 71 76 65 84 96
Total Expenditure -4 -6 -8 -49 -67 -70 -60 -78 -90
PBIDT -1 2 2 6 5 6 5 6 6
Interest 0 0 0 -1 -2 -3 -2 -3 -3
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 1 -1 -1 -1 0 -1 0
Exceptional Items
PAT -2 0 2 4 1 2 1 1 2

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 1 2 -6 -5 5 4 4 6
Cash Fr. Inv. -1 -1 -2 0 -2 -3 -3 -2 -7
Cash Fr. Finan. 1 1 0 6 7 -2 0 -1 0
Net Change 0 0 0 0 0 0 1 0 0
Cash & Cash Eqvt 0 0 0 0 1 1 2 2 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 54.00 54.00 54.00 55.86 55.86 55.86 55.86 55.86 56.13
Public 46.00 46.00 46.00 44.14 44.14 44.14 44.14 44.14 43.87
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 9.69 0.00 9.69 9.37 9.37 11.55 11.55 14.09 0.00

Announcements View Details

Fri, 23 Jul 2021
Fixes Book Closure for AGM
Godavari Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 07 2021 to August 14 2021 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on August 14 2021.
Thu, 22 Jul 2021
Reg. 34 (1) Annual Report
Annual report for the Financial year ended 31.03.2021.
Fri, 16 Jul 2021
Shareholding for the Period Ended June 30 2021
Godavari Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here

Technical Scans View Details

Thu, 29 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Close Within 2 Year High Zone Close Within 2 Year High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,733.23 703.00 +2.2%
Divi's Laboratories Ltd. 128,656.69 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. 77,707.65 4,672.65 -1.2%
Cipla Ltd. 71,170.06 883.10 -0.8%
Cadila Healthcare Ltd. 58,547.84 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. 58,067.43 4,028.55 0.0%
Aurobindo Pharma Ltd. 53,214.94 908.25 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.11 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 64.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 44.73 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 29.59 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 27.44 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 386.19 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 9.98 908.25 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 13.84 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.35 4,672.65 -1.2%
Cipla Ltd. Consolidated 2021-03 3.88 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 4.51 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.64 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.43 908.25 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 0.18 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 908.25 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 10.09 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 908.25 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 12.53 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 908.25 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 17,131.99 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 908.25 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 703.00 +2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,843.80 -1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,672.65 -1.2%
Cipla Ltd. Consolidated 2020-03 1,546.98 883.10 -0.8%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 572.00 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,028.55 0.0%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 908.25 -0.8%